Efficacy and tolerability of aripiprazole in adolescents with schizophrenia

被引：0
|
作者：
Forbes, A. [1 ]
Nyilas, M. [1 ]
Loze, J. [2 ]
Werner, C. [3 ]
Johnson, B. [1 ]
Owen, R. [4 ]
Todorov, S. [5 ]
Carson, W. H. [1 ]
机构：
[1] Otsuka Pharmaceut Dev & Commercializat, Princeton, NJ USA
[2] Otsuka Pharmaceut France SAS, Rueil Malmaison, France
[3] Otsuka Frankfurt Res Inst, Frankfurt, Germany
[4] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
[5] Multiprofiled Hosp Act Treatment, Psychiat Clin 1, Varna, Bulgaria
来源：
EUROPEAN PSYCHIATRY | 2008年 / 23卷
关键词：
D O I：
10.1016/j.eurpsy.2008.01.786
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S115 / S115
页数：1
相关论文
共 50 条
  • [1] Efficacy and tolerability of aripiprazole in adolescents with schizophrenia
    Nyilas, M.
    Forbes, A.
    Jin, N.
    Ashfaque, S.
    Iwamoto, T.
    Owen, R.
    Carson, W. H.
    Findling, R. L.
    EARLY INTERVENTION IN PSYCHIATRY, 2008, 2 : A99 - A99
  • [2] Efficacy of aripiprazole in the treatment of adolescents with schizophrenia
    Nyilas, M.
    Forbes, A.
    McQuade, R.
    Owen, R.
    Cox, K.
    Carson, W. H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S568 - S568
  • [3] Efficacy and tolerability of aripiprazole in outpatients with schizophrenia or schizoaffective disorder
    Shin, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S515 - S515
  • [4] Efficacy and tolerability of aripiprazole intramuscular as maintenance treatment in patients with paranoid schizophrenia
    Servan, B.
    Montes, A.
    Machin, M.
    Gomez, P.
    Garcia-Albea, J.
    Gonzalez, S.
    Ibanez, J.
    Moron, M. D.
    EUROPEAN PSYCHIATRY, 2017, 41 : S280 - S280
  • [5] Efficacy and tolerability of aripiprazole compared to perphenazine in treatment-resistant schizophrenia
    Kungel, M
    Ebrecht, M
    Modell, S
    Wagner, P
    Carson, W
    Marcus, R
    PHARMACOPSYCHIATRY, 2003, 36 (05) : 243 - 243
  • [6] Aripiprazole: In adolescents with schizophrenia
    Sanford M.
    Keating G.M.
    Pediatric Drugs, 2007, 9 (6) : 419 - 423
  • [7] A 6-week study of the efficacy and tolerability of aripiprazole in pediatric patients with schizophrenia
    Forbes, R.
    Werner, C.
    Nyilas, M.
    Jin, N.
    Aurang, C.
    Owen, R.
    Iwamoto, T.
    Carso, W.
    Findling, R.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 134 - 134
  • [8] Efficacy and tolerability of switching to long-acting injectable (LAI) aripiprazole in outpatients with schizophrenia
    Fernandez-Abascal Puente, B.
    Juncal Ruiz, M.
    Landera Rodriguez, R.
    EUROPEAN PSYCHIATRY, 2016, 33 : S255 - S256
  • [9] An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders
    Yoo, Hanik K.
    Choi, Soon-Ho
    Park, Subin
    Wang, Hee-Ryung
    Hong, Jin-Pyo
    Kim, Chang-Yoon
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (07) : 1088 - 1093
  • [10] Aripiprazole in adolescents with schizophrenia - Profile report
    Sanford, Mark
    Keating, Gillian M.
    CNS DRUGS, 2008, 22 (06) : 529 - 530
12345